Moreover, O-GlcNAcylation, a dynamic Ser/Thr glycosylation, can occur at or near these phosphorylation sites, competing with phosphorylation and sustaining Akt activation, contributing to chemoresistance and survival signaling in cancer cells [103]. The gene discussed is AKT1; the disease is cancer.